Loading fund overlap…
8 of 107 unique stocks in common · Jaccard: 7.5%
A weighted portfolio overlap of 8.73% indicates a low overlap (mostly different holdings). This means that out of every ₹100 you invest across these two schemes, approximately ₹8.73 is allocated to the exact same companies at the same relative proportions. The schemes share 8 common holdings.
The largest overlapping asset in their portfolios is Ajanta Pharma, which commands a weight of 4.05% in Aditya Birla Sun Life Pharma & Healthcare Fund and 1.88% in Kotak Small Cap Fund. Holding both schemes increases your concentration in Ajanta Pharma rather than expanding your diversification.
If the overlap is above 30%, it is typically because both schemes benchmark to the same index (e.g. Nifty 50 or Nifty LargeMidcap 250) or overlap in their top large-cap picks. To improve your portfolio's diversification, consider allocating one of these tranches to a category with lower structural correlation (such as a mid-cap, small-cap, or international equity fund).
| Stock | in Aditya | in Kotak |
|---|---|---|
| Ajanta PharmaPharmaceuticals & Biotechnology | 4.05% | 1.88% |
| Metropolis HealthcareHealthcare Services | 1.42% | 1.99% |
| Alembic PharmaceuticalsPharmaceuticals & Biotechnology | 1.35% | 1.42% |
| Mankind PharmaPharmaceuticals & Biotechnology | 3.88% | 1.06% |
| Vijaya Diagnostic CentreHealthcare Services | 0.98% | 4.04% |
| JB Chemicals & PharmaceuticalsPharmaceuticals & Biotechnology | 4.71% | 0.87% |
| Medi Assist Healthcare ServicesInsurance | 1.00% | 0.63% |
| Suraksha DiagnosticHealthcare Services | 1.06% | 0.54% |
Weighted overlap = Σ min(weight in fund A, weight in fund B) across shared stocks, from each fund's latest public monthly portfolio (as on May 2026). Equity holdings only, ISIN-verified. Not investment advice.